Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors

BACKGROUND: High-dose erythropoiesis-stimulating agents (ESA) for anemia of chronic kidney disease (CKD) have been associated with adverse clinical outcomes and do not always improve erythropoiesis. We hypothesized that high-dose ESA requirement would be associated with elevated inflammatory biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Inrig, Jula K, Bryskin, Suzanne K, Patel, Uptal D, Arcasoy, Murat, Szczech, Lynda A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254065/
https://www.ncbi.nlm.nih.gov/pubmed/22152013
http://dx.doi.org/10.1186/1471-2369-12-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254065/
https://www.ncbi.nlm.nih.gov/pubmed/22152013
http://dx.doi.org/10.1186/1471-2369-12-67

Ejemplares similares